Mda-9/Syntenin Is Expressed in Uveal Melanoma and Correlates with Metastatic Progression
Uveal melanoma is an aggressive cancer that metastasizes to the liver in about half of the patients, with a high lethality rate. Identification of patients at high risk of metastases may provide indication for a frequent follow-up for early detection of metastases and treatment. The analysis of the...
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Public Library of Science
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258266/ |
| id |
pubmed-3258266 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-32582662012-01-20 Mda-9/Syntenin Is Expressed in Uveal Melanoma and Correlates with Metastatic Progression Gangemi, Rosaria Mirisola, Valentina Barisione, Gaia Fabbi, Marina Brizzolara, Antonella Lanza, Francesco Mosci, Carlo Salvi, Sandra Gualco, Marina Truini, Mauro Angelini, Giovanna Boccardo, Simona Cilli, Michele Airoldi, Irma Queirolo, Paola Jager, Martine J. Daga, Antonio Pfeffer, Ulrich Ferrini, Silvano Research Article Uveal melanoma is an aggressive cancer that metastasizes to the liver in about half of the patients, with a high lethality rate. Identification of patients at high risk of metastases may provide indication for a frequent follow-up for early detection of metastases and treatment. The analysis of the gene expression profiles of primary human uveal melanomas showed high expression of SDCBP gene (encoding for syndecan-binding protein-1 or mda-9/syntenin), which appeared higher in patients with recurrence, whereas expression of syndecans was lower and unrelated to progression. Moreover, we found that high expression of SDCBP gene was related to metastatic progression in two additional independent datasets of uveal melanoma patients. More importantly, immunohistochemistry showed that high expression of mda-9/syntenin protein in primary tumors was significantly related to metastatic recurrence in our cohort of patients. Mda-9/syntenin expression was confirmed by RT-PCR, immunofluorescence and immunohistochemistry in cultured uveal melanoma cells or primary tumors. Interestingly, mda-9/syntenin showed both cytoplasmic and nuclear localization in cell lines and in a fraction of patients, suggesting its possible involvement in nuclear functions. A pseudo-metastatic model of uveal melanoma to the liver was developed in NOD/SCID/IL2Rγ null mice and the study of mda-9/syntenin expression in primary and metastatic lesions revealed higher mda-9/syntenin in metastases. The inhibition of SDCBP expression by siRNA impaired the ability of uveal melanoma cells to migrate in a wound–healing assay. Moreover, silencing of SDCBP in mda-9/syntenin-high uveal melanoma cells inhibited the hepatocyte growth factor (HGF)-triggered invasion of matrigel membranes and inhibited the activation of FAK, AKT and Src. Conversely syntenin overexpression in mda-9/syntenin-low uveal melanoma cells mediated opposite effects. These results suggest that mda-9/syntenin is involved in uveal melanoma progression and that it warrants further investigation as a candidate molecular marker of metastases and a potential therapeutic target. Public Library of Science 2012-01-13 /pmc/articles/PMC3258266/ /pubmed/22267972 http://dx.doi.org/10.1371/journal.pone.0029989 Text en Gangemi et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Gangemi, Rosaria Mirisola, Valentina Barisione, Gaia Fabbi, Marina Brizzolara, Antonella Lanza, Francesco Mosci, Carlo Salvi, Sandra Gualco, Marina Truini, Mauro Angelini, Giovanna Boccardo, Simona Cilli, Michele Airoldi, Irma Queirolo, Paola Jager, Martine J. Daga, Antonio Pfeffer, Ulrich Ferrini, Silvano |
| spellingShingle |
Gangemi, Rosaria Mirisola, Valentina Barisione, Gaia Fabbi, Marina Brizzolara, Antonella Lanza, Francesco Mosci, Carlo Salvi, Sandra Gualco, Marina Truini, Mauro Angelini, Giovanna Boccardo, Simona Cilli, Michele Airoldi, Irma Queirolo, Paola Jager, Martine J. Daga, Antonio Pfeffer, Ulrich Ferrini, Silvano Mda-9/Syntenin Is Expressed in Uveal Melanoma and Correlates with Metastatic Progression |
| author_facet |
Gangemi, Rosaria Mirisola, Valentina Barisione, Gaia Fabbi, Marina Brizzolara, Antonella Lanza, Francesco Mosci, Carlo Salvi, Sandra Gualco, Marina Truini, Mauro Angelini, Giovanna Boccardo, Simona Cilli, Michele Airoldi, Irma Queirolo, Paola Jager, Martine J. Daga, Antonio Pfeffer, Ulrich Ferrini, Silvano |
| author_sort |
Gangemi, Rosaria |
| title |
Mda-9/Syntenin Is Expressed in Uveal Melanoma and Correlates with Metastatic Progression |
| title_short |
Mda-9/Syntenin Is Expressed in Uveal Melanoma and Correlates with Metastatic Progression |
| title_full |
Mda-9/Syntenin Is Expressed in Uveal Melanoma and Correlates with Metastatic Progression |
| title_fullStr |
Mda-9/Syntenin Is Expressed in Uveal Melanoma and Correlates with Metastatic Progression |
| title_full_unstemmed |
Mda-9/Syntenin Is Expressed in Uveal Melanoma and Correlates with Metastatic Progression |
| title_sort |
mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression |
| description |
Uveal melanoma is an aggressive cancer that metastasizes to the liver in about half of the patients, with a high lethality rate. Identification of patients at high risk of metastases may provide indication for a frequent follow-up for early detection of metastases and treatment. The analysis of the gene expression profiles of primary human uveal melanomas showed high expression of SDCBP gene (encoding for syndecan-binding protein-1 or mda-9/syntenin), which appeared higher in patients with recurrence, whereas expression of syndecans was lower and unrelated to progression. Moreover, we found that high expression of SDCBP gene was related to metastatic progression in two additional independent datasets of uveal melanoma patients. More importantly, immunohistochemistry showed that high expression of mda-9/syntenin protein in primary tumors was significantly related to metastatic recurrence in our cohort of patients. Mda-9/syntenin expression was confirmed by RT-PCR, immunofluorescence and immunohistochemistry in cultured uveal melanoma cells or primary tumors. Interestingly, mda-9/syntenin showed both cytoplasmic and nuclear localization in cell lines and in a fraction of patients, suggesting its possible involvement in nuclear functions. A pseudo-metastatic model of uveal melanoma to the liver was developed in NOD/SCID/IL2Rγ null mice and the study of mda-9/syntenin expression in primary and metastatic lesions revealed higher mda-9/syntenin in metastases. The inhibition of SDCBP expression by siRNA impaired the ability of uveal melanoma cells to migrate in a wound–healing assay. Moreover, silencing of SDCBP in mda-9/syntenin-high uveal melanoma cells inhibited the hepatocyte growth factor (HGF)-triggered invasion of matrigel membranes and inhibited the activation of FAK, AKT and Src. Conversely syntenin overexpression in mda-9/syntenin-low uveal melanoma cells mediated opposite effects. These results suggest that mda-9/syntenin is involved in uveal melanoma progression and that it warrants further investigation as a candidate molecular marker of metastases and a potential therapeutic target. |
| publisher |
Public Library of Science |
| publishDate |
2012 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258266/ |
| _version_ |
1611499956315619328 |